Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Detection of JAK2 mutations in paraffin marrow biopsies by high resolution melting analysis: identification of L611S alone and in cis with V617F in polycythemia vera.

Nussenzveig RH, Burjanivova T, Salama ME, Ogilvie NW, Marcinek J, Plank L, Agarwal AM, Perkins SL, Prchal JT.

Leuk Lymphoma. 2012 Dec;53(12):2479-86. doi: 10.3109/10428194.2012.697562. Epub 2012 Jul 9.

PMID:
22642932
2.

A novel JAK2 exon 12 mutation identified in the retrospective analysis of paraffin-embedded tissues of polycythemia vera patients.

Burjanivova T, Marcinek J, Lasabova Z, Minarik G, Szepe P, Balharek T, Vanochova A, Polacek H, Plank L.

Diagn Mol Pathol. 2009 Jun;18(2):108-11. doi: 10.1097/PDM.0b013e318190eed0.

PMID:
19430293
3.

Bone marrow morphologic features in polycythemia vera with JAK2 exon 12 mutations.

Lakey MA, Pardanani A, Hoyer JD, Nguyen PL, Lasho TL, Tefferi A, Hanson CA.

Am J Clin Pathol. 2010 Jun;133(6):942-8. doi: 10.1309/AJCP3Z2AKUWRGTNM.

PMID:
20472853
4.

Detection of JAK2 Exon 12 Mutations in JAK2 V617F-Negative Polycythemia Vera Patients by Cloning Technique.

Leszczynska A, Grzenkowicz-Wydra J, Chmielewska-Gorycka L, Bieniaszewska M, Hellmann A.

Acta Haematol. 2016;136(2):123-8. doi: 10.1159/000446798. Epub 2016 Jul 14.

PMID:
27410038
5.

Detection of low allele burden of JAK2 exon 12 mutations using TA-cloning in patients with erythrocytosis.

Ohyashiki JH, Hisatomi H, Shimizu S, Sugaya M, Ohyashiki K.

Jpn J Clin Oncol. 2009 Aug;39(8):509-13. doi: 10.1093/jjco/hyp048. Epub 2009 Jun 2.

PMID:
19491085
6.

High percentage of JAK2 exon 12 mutation in Asian patients with polycythemia vera.

Yeh YM, Chen YL, Cheng HY, Su WC, Chow NH, Chen TY, Ho CL.

Am J Clin Pathol. 2010 Aug;134(2):266-70. doi: 10.1309/AJCPK7KGOWPHYWM0.

PMID:
20660330
7.

[Our experience with detection of JAK2 mutations in paraffin-embedded trephine bone marrow biopsies of patients with chronic myeloproliferative disorders].

Burjanivová T, Marcinek J, Minárik G, Lasabová Z, Szépe P, Balhárek T, Vanochová A, Plank L.

Cesk Patol. 2011 Jul;47(3):115-7. Slovak.

PMID:
21887928
8.

The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels.

Percy MJ, Scott LM, Erber WN, Harrison CN, Reilly JT, Jones FG, Green AR, McMullin MF.

Haematologica. 2007 Dec;92(12):1607-14.

9.

JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.

Scott LM, Tong W, Levine RL, Scott MA, Beer PA, Stratton MR, Futreal PA, Erber WN, McMullin MF, Harrison CN, Warren AJ, Gilliland DG, Lodish HF, Green AR.

N Engl J Med. 2007 Feb 1;356(5):459-68.

10.

Detection of the activating JAK2 V617F mutation in paraffin-embedded trephine bone marrow biopsies of patients with chronic myeloproliferative diseases.

Horn T, Kremer M, Dechow T, Pfeifer WM, Geist B, Perker M, Duyster J, Quintanilla-Martinez L, Fend F.

J Mol Diagn. 2006 Jul;8(3):299-304.

11.

Interlaboratory development and validation of a HRM method applied to the detection of JAK2 exon 12 mutations in polycythemia vera patients.

Ugo V, Tondeur S, Menot ML, Bonnin N, Le Gac G, Tonetti C, Mansat-De Mas V, Lecucq L, Kiladjian JJ, Chomienne C, Dosquet C, Parquet N, Darnige L, Porneuf M, Escoffre-Barbe M, Giraudier S, Delabesse E, Cassinat B; French Intergroup of Myeloproliferative disorders.

PLoS One. 2010 Jan 26;5(1):e8893. doi: 10.1371/journal.pone.0008893.

12.

Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera.

Schnittger S, Bacher U, Haferlach C, Geer T, Müller P, Mittermüller J, Petrides P, Schlag R, Sandner R, Selbach J, Slawik HR, Tessen HW, Wehmeyer J, Kern W, Haferlach T.

Haematologica. 2009 Mar;94(3):414-8. doi: 10.3324/haematol.13223.

13.

Clonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutations.

Li S, Kralovics R, De Libero G, Theocharides A, Gisslinger H, Skoda RC.

Blood. 2008 Apr 1;111(7):3863-6. doi: 10.1182/blood-2007-09-111971. Epub 2008 Jan 14.

14.

Analysis of JAK2V617F mutation in Jordanian patients with myeloproliferative neoplasms.

Jaradat SA, Khasawneh R, Kamal N, Matalka I, Al-Bishtawi M, Al-Sweedan S, Ayesh MH.

Hematol Oncol Stem Cell Ther. 2015 Dec;8(4):160-6. doi: 10.1016/j.hemonc.2015.07.004. Epub 2015 Aug 1.

15.

Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).

Michiels JJ, Bernema Z, Van Bockstaele D, De Raeve H, Schroyens W.

Pathol Biol (Paris). 2007 Mar;55(2):92-104. Epub 2006 Aug 21. Review.

PMID:
16919893
16.

Different involvement of the megakaryocytic lineage by the JAK2 V617F mutation in Polycythemia vera, essential thrombocythemia and chronic idiopathic myelofibrosis.

Hussein K, Brakensiek K, Buesche G, Buhr T, Wiese B, Kreipe H, Bock O.

Ann Hematol. 2007 Apr;86(4):245-53. Epub 2007 Jan 30.

PMID:
17262192
17.

Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.

Vytrva N, Stacher E, Regitnig P, Zinke-Cerwenka W, Hojas S, Hubmann E, Porwit A, Bjorkholm M, Hoefler G, Beham-Schmid C.

Arch Pathol Lab Med. 2014 Sep;138(9):1203-9. doi: 10.5858/arpa.2013-0018-OA.

PMID:
25171702
18.

High frequency of JAK2 exon 12 mutations in Korean patients with polycythaemia vera: novel mutations and clinical significance.

Park CH, Lee KO, Jang JH, Jung CW, Kim JW, Kim SH, Kim HJ.

J Clin Pathol. 2016 Aug;69(8):737-41. doi: 10.1136/jclinpath-2016-203649. Epub 2016 May 19.

PMID:
27198504
20.

Nested high-resolution melting curve analysis a highly sensitive, reliable, and simple method for detection of JAK2 exon 12 mutations--clinical relevance in the monitoring of polycythemia.

Carillo S, Henry L, Lippert E, Girodon F, Guiraud I, Richard C, Dubois Galopin F, Cleyrat C, Jourdan E, Kralovics R, Hermouet S, Lavabre-Bertrand T.

J Mol Diagn. 2011 May;13(3):263-70. doi: 10.1016/j.jmoldx.2010.12.002.

Supplemental Content

Support Center